Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06511778
PHASE4

sTErnAl heMostasiS Trial

Sponsor: WakeMed Health and Hospitals

View on ClinicalTrials.gov

Summary

Sternal bleeding remains an unsolved problem for cardiac surgery teams costing operative time, blood loss, and distraction from the critical operative field. As such, the following is an investigator-initiated trial to determine whether application of a topical hemostatic agent reduces sternal bleeding during cardiac surgery using sternotomy approach.

Official title: sTErnAl heMostasiS Trial (TEAMS Trial)

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-10-17

Completion Date

2026-09

Last Updated

2025-09-11

Healthy Volunteers

No

Interventions

DRUG

Hemoblast Bellows application

Hemoblast bellows is a hemostatic agent clinically proven effective on the validated SPOT GRADE scale for minimal, mild, and moderate bleeding. Patients will have the Hemoblast bellows applied during on pump sternotomy surgery.

Locations (1)

WakeMed Health and Hospitals

Raleigh, North Carolina, United States